SCHEMBL31093147

SCHEMBL31093147

COCCN(CCC(=O)c1ccccc1)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.51
EGFR P00533 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
TDP1 Q9NUW8 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MEP1B Q16820 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PTK2B Q14289 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31093129 0.90 KMT2A (0.59) KMT2AEGFRNPC1RAB9ASMN1; SMN2
SCHEMBL8725187 0.85 KMT2A (0.59) KMT2AEGFRNPC1RAB9ASMN1; SMN2
SCHEMBL31093162 0.83 MEN1 (0.39) KMT2ASMN1; SMN2MEP1BKDM4EHDAC1
SCHEMBL8281042 0.83 MEN1 (0.51) KMT2ASMN1; SMN2LMNAALDH1A1PTK2B
SCHEMBL8281044 0.79 MEN1 (0.51) KMT2ASMN1; SMN2ALDH1A1PTK2BL3MBTL1
SCHEMBL4744604 0.77 MEP1B (0.51) KMT2ANPC1RAB9ASMN1; SMN2MEP1B
SCHEMBL9504529 0.77 MEN1 (0.48) KMT2ASMN1; SMN2TDP1KDM4ELMNA
SCHEMBL31093105 0.77 KMT2A (0.54) KMT2AEGFRNPC1RAB9ASMN1; SMN2
SCHEMBL18926361 0.76 ALDH1A1 (0.45) KMT2ASMN1; SMN2TDP1HDAC1HDAC6
SCHEMBL1697056 0.76 MAPT (0.57) KMT2ANPC1RAB9ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME INFINEUM INTERNATIONAL LIMITED (GB) 2024-08-29 US disclosed
EP-4410772-A2 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME Infineum International Limited (GB) 2024-08-07 EP disclosed
CN-118440229-A Amine functional monomers and methods of making the same 英菲诺姆国际有限公司 2024-08-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME AMD1, HNMT, MAT1A KMT2A 134/4885EGFR 2938/4885NPC1 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.